I
ImmunityBio, Inc. (IBRX)
NMS – Real Time Price. Currency in USD
7.68
+0.08 (1.05%)
Market open: Aug 12, 2026, 12:29 PM EDT
7.60
0.00 (0.00%)
Previous after-hours: Aug 11, 2026, 7:59 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
7.68
+0.08 (1.05%)
Market open: Aug 12, 2026, 12:29 PM EDT
7.60
0.00 (0.00%)
Previous after-hours: Aug 11, 2026, 7:59 PM EDT
No Data
There are no news for this stock.
Cash reserves $0.0 barely cover the upcoming debt maturities $0.0
Total current assets $0.0 are just enough to cover Total current liabilities $0.0, indicating tight liquidity
Debt-to-equity ratio (0.0) is near the industry average, reflecting balanced leverage
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | N/A | 6.05 | 1.0 | |
| Quick ratio | N/A | 5.63 | 1.0 | |
| Debt to Equity | N/A | 0.30 | 1.0 | |
| Debt to Assets | N/A | 1.04 | 1.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 1.0 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 240K | 622K | 15M | 113M | 115M |
| Gross Profit | -24M | -18M | -3M | 97M | 102M |
| Operating Income | -351M | -361M | -344M | -256M | -252M |
| Net Income | -417M | -583M | -414M | -351M | -992M |
| EBITDA | -326M | -343M | -327M | -241M | -178M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 84.73 | 0 | 5.5 |
| Next quarter | 86.01 | -8.33 | 5.5 |
| Current year | 99.12 | -152.63 | 5.5 |
| Next year | 95.7 | 85.16 | 10 |
| Weighted average score | 6.6 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 15.47 | 63.59 | 64.52 | -8.27 | 7.5 |
| Y/Y | 167.64 | -148.9 | -119.99 | 11.35 | 4.8 |
| 3y average | 1032.69 | 1.38 | 24.74 | 8.89 | 7.3 |
| 5y average | 753.04 | -58.26 | 11.48 | -65.92 | 4.8 |
| Weighted average score | 6.1 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | Medium | 7.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 2.2 | |